Viewing Study NCT02530060


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-02-12 @ 9:15 AM
Study NCT ID: NCT02530060
Status: COMPLETED
Last Update Posted: 2017-01-02
First Post: 2015-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male Participants
Sponsor: Janssen Pharmaceutical K.K.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-08
Start Date Type: None
Primary Completion Date: 2015-09
Primary Completion Date Type: ACTUAL
Completion Date: 2015-09
Completion Date Type: ACTUAL
First Submit Date: 2015-08-19
First Submit QC Date: None
Study First Post Date: 2015-08-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-12-30
Last Update Post Date: 2017-01-02
Last Update Post Date Type: ESTIMATED